Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Clinigene International, a unit of Indian biotech firm Biocon has formed an alliance with Scirex, a subsidiary of the Omnicom Group, to collaborate on global clinical trials. The research will allow the companies access to wider markets and to expand their clinical expertise.
Subscribe to our email newsletter
The new relationship is designed to provide Scirex with immediate access to well developed expertise in clinical investigation in India whilst giving Clinigene the opportunity to expand its markets and partake in global clinical trial programs.
Scirex CEO Jim Utterback said: “This brings our clients a best in class firm that not only offers them substantial value based on cost efficiencies and great science but also demonstrated clinical trial expertise. Scirex and our parent Omnicom Group can be truly integrated research and commercialization partners with Clinigene for years to come.”
Although the exact nature of the research was undisclosed, Dr Arvind Atignal, chief operating officer at Clinigene said the partnership would help further the position of both companies as world-class clinical development organizations.